Skip to main navigation

Technology & Pipeline
Medicines
Disease Overview
Investors
About Us
Careers
Menu

Press Releases

Press Releases

Press Releases

Year

October 1, 2020

Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer

PDF Version

September 15, 2020

Intra-Cellular Therapies to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

PDF Version

September 14, 2020

Intra-Cellular Therapies to Present at the Cantor Virtual Global Healthcare Conference

PDF Version

September 10, 2020

Intra-Cellular Therapies Prices Public Offering of Common Stock

PDF Version

September 9, 2020

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

PDF Version

September 9, 2020

Intra-Cellular Therapies Announces Positive Topline Results from Study 402 Evaluating Lumateperone as Adjunctive Therapy in Patients with Bipolar Depression

PDF Version

August 10, 2020

Intra-Cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update

PDF Version

August 4, 2020

Intra-Cellular Therapies to Host Second Quarter 2020 Financial Results Conference Call and Webcast

PDF Version

June 29, 2020

Intra-Cellular Therapies Announces Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Heart Failure

PDF Version

May 14, 2020

Intra-Cellular Therapies to Present at the 2020 RBC Capital Markets Global Healthcare Conference

PDF Version

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Shareholder Tools

Corporate Governance
Analyst Coverage
Email Alerts
Downloads
RSS News Feeds
Print
Share
Printed Materials
IR Search

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

OK Privacy Policy Cookies Policy

Contact Us

X

Facebook
Google
LinkedIn
Twitter

© 2020 Intra-Cellular Therapies Inc. All rights reserved.

Copyrights Line Links

Term of Use
Privacy Policy
Cookies Policy
Site Map